Effects of Pharmacogenomic Testing in Clinical Pain Management: Retrospective Study
BackgroundThe availability of pharmacogenomic (PGx) methods to determine the right drug and dosage for individualized patient treatment has increased over the past decade. Adoption of the resulting PGx reports in a clinical setting and monitoring of clinical outcomes is a cha...
Main Authors: | Christian Tagwerker, Mary Jane Carias-Marines, David J Smith |
---|---|
Format: | Article |
Language: | English |
Published: |
JMIR Publications
2022-05-01
|
Series: | JMIRx Med |
Online Access: | https://med.jmirx.org/2022/2/e32902 |
Similar Items
-
Authors' Response to Peer Reviews of “Effects of Pharmacogenomic Testing in Clinical Pain Management: Retrospective Study”
by: Christian Tagwerker, et al.
Published: (2022-05-01) -
Peer Review of “Effects of Pharmacogenomic Testing in Clinical Pain Management: Retrospective Study”
by: Komal Rathi
Published: (2022-05-01) -
Peer Review of “Effects of Pharmacogenomic Testing in Clinical Pain Management: Retrospective Study”
by: Madara Hetti Arachchilage
Published: (2022-05-01) -
Update on the pharmacogenomics of pain management
by: Kaye AD, et al.
Published: (2019-07-01) -
Pharmacogenomics of neuropathic pain
by: Vandana Sharma
Published: (2017-01-01)